Republican Sen. Charles E. Grassley has sent letters to the American Medical Association, the American Cancer Society, and 31 other disease and medical advocacy organizations asking them to provide details about the amount of money that they and their directors receive from drug and device makers. Such funding amounts are often considered proprietary by the organizations and their directors, but critics contend that the industry's sway over such groups leads them to lobby on industry's behalf.
